Tower Research Capital (TRC)’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Buy |
|
|||||
|
2025
Q1 | $22.9K | Sell |
|
|||||
|
2024
Q4 | $655K | Buy |
|
|||||
|
2024
Q3 | $84.1K | Sell |
|
|||||
|
2024
Q2 | $127K | Buy |
|
|||||
|
2024
Q1 | $19.2K | Sell |
|
|||||
|
2023
Q4 | $50.8K | Sell |
|
|||||
|
2023
Q3 | $140K | Buy |
|
|||||
|
2023
Q2 | $118K | Buy |
|
|||||
|
2023
Q1 | $82K | Buy |
|
|||||
|
2022
Q4 | $5K | Sell |
|
|||||
|
2022
Q3 | $167K | Buy |
|
|||||
|
2022
Q2 | $33K | Buy |
|
|||||
|
2022
Q1 | $45K | Buy |
|
|||||
|
2021
Q4 | $0 | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $2K | Sell |
|
|||||
|
2020
Q4 | $23K | Buy |
|
|||||
|
2020
Q3 | $1K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $22K | Buy |
|
|||||
|
2019
Q1 | $17K | Buy |
|
|||||
|
2018
Q4 | $15K | Sell |
|
|||||
|
2018
Q3 | $34K | Buy |
|
|||||
|
2018
Q2 | $19K | Sell |
|
|||||
|
2018
Q1 | $89K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $14K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $17K | Buy |
|
|||||
|
2014
Q4 | $5K | Hold |
|
|||||
|
2014
Q3 | $9K | Buy |
|